Current Hpv Vaccination News and Events

Current Hpv Vaccination News and Events, Hpv Vaccination News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
International study finds increased COVID-19 mortality among adults with Down syndrome
A new study by an international team of researchers found that adults with Down syndrome are more likely to die from COVID-19 than the general population, supporting the need to prioritize vaccinating people with the genetic disorder. (2021-02-22)

Researchers learn that pregnant women pass along protective COVID antibodies to their babies
Antibodies that guard against COVID-19 can transfer from mothers to babies while in the womb, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers published in the American Journal of Obstetrics and Gynecology. (2021-02-22)

Combined vaccination and physical distancing enough to prevent future COVID-19 surges
A combination of robust vaccination programmes and strict physical distancing could avoid recurring peaks of COVID-19 without the need for stay-at-home restrictions, according to a new study by epidemiologists and demographers from WorldPop at the University of Southampton and The Chinese University of Hong Kong. Using anonymised mobile phone geolocation data with epidemiological and coronavirus case data from China, the team predicted the effect of combinations of interventions on low, medium and high density cities. (2021-02-19)

The Lancet Healthy Longevity: Study finds racial and ethnic disparities in flu vaccine uptake among people aged 65 and older in the USA
A new study published today in The Lancet Healthy Longevity journal has found significant racial and ethnic disparities in uptake of the seasonal influenza vaccine among people aged 65 years and over in the USA. (2021-02-18)

New research finds drive-through mass-vaccination clinics could alter COVID-19 trajectory
Policymakers at all levels of government are racing to vaccinate hundreds of millions of people to save lives and blunt the deadly COVID-19 pandemic. New research published in the INFORMS Journal on Applied Analytics provides a simulated model for drive-through clinics that can be used for mass COVID-19 vaccinations based on the successful use of such a clinic to address H1N1. (2021-02-17)

COVID-19 infection rates high in pregnant women
The study also showed that the number of COVID-19 infections in pregnant patients from nearly all communities of color in Washington was high. There was a twofold to fourfold higher prevalence of pregnant patients with COVID-19 infections from communities of color than expected based on the race-ethnicity distribution of pregnant women in Washington in 2018. (2021-02-16)

The Lancet: COVID-19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout
Having new COVID-19 vaccines will mean little if people around the world are unable to get vaccinated in a timely manner. Vaccines have to be affordable and available to all countries, and governments must have the administrative and political capacities to deliver them locally to ensure an effective global immunisation strategy against COVID-19, say the authors of a Health Policy piece published in The Lancet. (2021-02-12)

New ACIP Adult Immunization Schedule recommends changes to several vaccines, includes interim recomm
The Advisory Committee on Immunization Practices (ACIP) has released its 2021 Recommended Adult Immunization Schedule that includes changes to several vaccines including influenza, hepatitis A, human papillomavirus (HPV); and the measles, mumps and rubella (MMR) vaccine. The schedule also includes interim recommendations for COVID-19 vaccination. The complete schedule, including changes in the vaccine notes section, is being simultaneously published in Annals of Internal Medicine and on the Centers for Disease Control and Prevention (CDC) web site. (2021-02-11)

One dose of COVID-19 vaccine provokes strong immune response in those previously infected
Researchers report preliminary evidence that people previously infected with COVID-19 responded very strongly to one dose of the Pfizer vaccine, regardless of when they were infected and whether or not they had detectable antibodies against COVID-19 prior to receiving the vaccine. The response was so effective that it opens the debate as to whether one dose of the vaccine may suffice. The research also provided evidence that immune response was similar across multi-ethnic groups. (2021-02-11)

Study predicts UK COVID-19 vaccination program will very quickly reduce deaths but more slowly bring down hospital and ICU admissions
A new modelling study published in Anaesthesia (a journal of the Association of Anaesthetists) shows that the UK's coronavirus vaccination program is already reducing daily deaths. However, reductions of hospital and intensive care (ICU) admissions will likely take several weeks longer, with large reductions seen by the end of March and continuing into April. (2021-02-11)

Oncotarget: Combination of copanlisib with cetuximab improves tumor response
''These data support further investigation of PI3K inhibition in HNSCC and suggests gene expression patterns associated with PI3K signaling'' (2021-02-10)

Experts' top COVID mitigation action: Nat'l stay at home order with financial compensation
A report summary released today by a team at Lehigh University led by Thomas McAndrew, a computational scientist and assistant professor in Lehigh's College of Health, shares the consensus results of experts in the modeling of infectious disease when asked to rank the top 5 most effective interventions to mitigate the spread and impact of COVID-19 in the US. (2021-02-10)

The genetic susceptibility of people with Down's syndrome to COVID-19
A study reveals the genetic factors that may expose or protect people with Down syndrome from SARS-CoV-2. TMPRSS2, a gene that codes for an enzyme critical for aiding the entry of SARS-CoV-2 in human cells, had 60% higher levels of expression in Down syndrome. The researchers also found higher expression levels for CXCL10, a gene that can trigger cytokine storms. The authors call to vaccinate people with Down syndrome against COVID-19 as a priority. (2021-02-08)

Higher excess COVID-19 death risk in middle-aged people with type 2 diabetes
A largescale analysis led by the University of Exeter and funded by Diabetes UK, has found a disproportionately higher COVID-19 death risk in middle-aged people with type 2 diabetes, raising questions over vaccination strategies across Europe. (2021-02-08)

The Lancet Public Health: Survey taken after France's first COVID-19 wave indicates almost one-third of working-age people could reject a vaccine
Nearly one in three working-age adults in France (29%) surveyed in July 2020 - when lockdown restrictions had been eased - were outright opposed to being vaccinated against the virus, according to new research published in The Lancet Public Health journal. (2021-02-05)

Study shows flu vaccine lessens COVID-19 symptoms in children
Researchers from the University of Missouri School of Medicine have discovered that children who receive a seasonal flu shot are less likely to suffer symptoms from a COVID-19 infection. The finding comes from a review of more than 900 children diagnosed with COVID-19 in 2020. (2021-02-04)

Dialysis patients have 4-fold greater risk of dying from COVID-19
People undergoing long-term dialysis are almost 4 times more likely to die from COVID-19 and should be prioritized for vaccination, found a new Ontario study published in CMAJ (Canadian Medical Association Journal). (2021-02-04)

COVID-19 vaccine from new vaccine platform effective in mice
It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically. Researchers at Karolinska Institutet in Sweden now report that they have developed a prototype vaccine against SARS-CoV-2 using a DNA vaccine platform that is inexpensive, stable, easy to produce, and shows a good safety profile. A study published in Scientific Reports shows that the vaccine induces potent immune responses in mice. (2021-02-04)

Unusual 2019-2020 flu season linked to more transmissible strain
The 2019-2020 flu season in the U.S. was unusual in a number of ways. Cases picked up in August rather than the more typical fall and early winter months, and it hit children particularly hard. (2021-02-04)

Retrained generic antibodies can recognize SARS-CoV-2
An alternative approach to train the immunity response is offered by researchers at the University of Illinois Chicago and California State University at Sacramento who have developed a novel strategy that redirects antibodies for other diseases existing in humans to the spike proteins of SARS-CoV-2. (2021-02-03)

COVID-19 vaccination for patients with Parkinson's disease recommended
Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment. In a commentary just published in the Journal of Parkinson's Disease, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with PD, unless there is a specific contraindication. (2021-02-03)

Spanish scientists identify a mechanism through which dendritic cells improve their antiviral and immunotherapy strategies
Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered that dendritic cells, which initiate specific immune responses, can reprogram their genes to improve their immune response (2021-02-03)

The Lancet: Study reports preliminary efficacy and safety results from interim analysis of Russian COVID-19 phase 3 vaccine trial
An interim analysis of data from the phase 3 trial of the COVID-19 vaccine from Russia (Gam-COVID-Vac) suggests that a two-dose regimen of the adenovirus-based vaccine offers 91.6% efficacy against symptomatic COVID-19. The preliminary findings, published in The Lancet, are based on analysis of data from nearly 20,000 participants, three-quarters of whom received the vaccine and one quarter received a placebo. (2021-02-02)

Reduced-dose RT with Cisplatin improves outcomes for HPV-associated oropharyngeal carcinoma
A combination of reduced-dose radiotherapy using intensity-modulated radiotherapy (IMRT) combined with concurrent cisplatin met the threshold for disease control and quality of life compared to the standard of care for good-risk patients with HPV-associated oropharyngeal squamous cell carcinoma on the NRG Oncology clinical trial NRG-HN002. (2021-01-29)

A third of Americans say they are unlikely or hesitant to get COVID-19 vaccine
A University of California, Davis, study found that more than a third of people nationwide are either unlikely or at least hesitant to get a COVID-19 vaccine when it becomes available to them. (2021-01-29)

Forecast :125,000 fewer U.S. COVID deaths if 50% initiate vaccination by March 1
A new report combining forecasting and expert prediction data, predicts that 125,000 lives could be saved by the end of 2021 if 50% or more of the U.S. population initiated COVID vaccination by March 1, 2021. (2021-01-29)

The Lancet: Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries
Vaccinations against 10 major pathogens have a substantial impact on public health in low-income and middle-income countries (LMICs), according to new modelling research published in The Lancet. The study estimated that from 2000 to 2019 vaccinations have prevented 37 million deaths, and that this figure will increase to 69 million deaths for the period 2000-2030. Most of this impact is estimated to be among children younger than five years, most notably from measles vaccinations. (2021-01-28)

Antibody highs and lows in survivors of Ebola
A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found. Published today in Nature, the finding hints that hidden reservoirs of virus could exist long after symptoms ease and has implications for monitoring programmes and vaccine strategies. (2021-01-27)

Offer COVID-19 vaccines to pregnant or breastfeeding people
People who are pregnant, breastfeeding or trying to conceive should be offered the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine based on ethical grounds, argue authors of a commentary in CMAJ (Canadian Medical Association Journal) (2021-01-27)

Hospital worker flu shots could mean fewer deaths
Research shows that state laws promoting flu vaccinations for hospital workers can substantially reduce the number of influenza-related deaths. (2021-01-26)

Governments need to set clear rules for vaccinating health care workers against COVID-19
An analysis undertaken by Faculty of Law professors and a physician-researcher from the Faculty of Medicine at the University of Ottawa feels provincial and territorial governments should set clear rules for vaccinating health care workers against SARS-CoV-2, the virus that causes COVID-19, in public and private settings. (2021-01-25)

Continued strict control measures needed to reduce new COVID-19 strains
A group of scientists is calling on governments to consider the continued use of strict control measures as the only way to reduce the evolution and spread of new COVID-19 variants. The experts in evolution, virology, infectious disease and genomics warn that while governments are negotiating a 'precarious balance' between saving the economy and preventing COVID-19 fatalities, stronger action now is the best way to mitigate against more serious outcomes from such virulent strains later. (2021-01-24)

Massey researchers review geographic factors that affect HPV vaccination rates
A team of researchers from VCU Massey Cancer Center conducted the first-ever systematic review of area-level data reported in the United States between 2006 and 2020 to determine how geography, neighborhoods and sociodemographic factors impact HPV vaccination rates among adolescents and young adults. The study was published in Cancer Epidemiology, Biomarkers and Prevention. (2021-01-22)

NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests
New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology. (2021-01-22)

Research finds people more likely to follow Covid rules when friends and family do
New research has shown that people are more likely to follow Covid-19 restrictions based on what their friends do, rather than their own principles. (2021-01-21)

Social influence matters when it comes to following pandemic guidelines
New research published in the British Journal of Psychology indicates that social influence has a large impact on people's adherence to COVID-19 guidelines. (2021-01-21)

Age-based COVID-19 vaccine strategy that saves most lives prioritizes elderly, modeling shows
Vaccinating people over 60 is the most effective way to mitigate mortality from COVID-19, a new age-based modeling study suggests. (2021-01-21)

Hope for a vaccination against Staphylococcus areus infections?
Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunisation against multi-resistant strains is seen as a potentially valuable alternative to antibiotic therapy. However, all vaccine candidates so far have been clinically unsuccessful. With an epitope-based immunisation, scientists at Cologne University Hospital and the German Center for Infection Research (DZIF) have now described a new vaccination strategy against S. aureus in the Nature Partner Journal NPJ VACCINES. (2021-01-20)

Set clear rules for vaccinating health care workers against SARS-CoV-2
Provincial and territorial governments should set clear rules for vaccinating health care workers against SARS-CoV-2, the virus that causes COVID-19, in public and private settings, and should not leave this task to employers, according to an analysis in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/content/cmaj/early/2021/01/19/cmaj.202755.full.pdf. (2021-01-19)

New COVID-19 model shows little benefit in vaccinating high-risk individuals first
Maurizio Porfiri, Institute Professor at the NYU Tandon School of Engineering, led a team that developed a novel theory and simulation platform for modeling COVID spread over the entire town of New Rochelle, located in Westchester County in New York State. The paper, ''High-Resolution Agent-Based Modeling of COVID-19 Spreading in a Small Town,'' published in Advanced Theory and Simulations, details the findings. (2021-01-19)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.